HomeHealthcare & Life Sciences Glucagon Delivery Device Market

Glucagon Delivery Device Market Size, Share & Demand Report By Product Type (Autoinjectors, Prefilled Syringes, Nasal Devices), By Application (Severe Hypoglycemia, Exercise-Induced Hypoglycemia), By End-Use (Hospitals, Clinics, Homecare Settings), By Region & Segment Forecasts, 2026–2034

Starting From
USD 3950
Buy Now

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.

  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

  • Track sales in the global and country-specific Market.

  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Glucagon Delivery Device Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Glucagon Delivery Device Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Glucagon Delivery Device Market, Product Type
    1. Introduction
      1. Market Size and Forecast, Product Type
    2. Autoinjectors
      1. Market Size and Forecast, By Region
    3. Prefilled Syringes
      1. Market Size and Forecast, By Region
    4. Nasal Devices
      1. Market Size and Forecast, By Region
  10. Glucagon Delivery Device Market, Application
    1. Introduction
      1. Market Size and Forecast, Application
    2. Severe Hypoglycemia
      1. Market Size and Forecast, By Region
    3. Exercise-Induced Hypoglycemia
      1. Market Size and Forecast, By Region
  11. Glucagon Delivery Device Market, End-Use
    1. Introduction
      1. Market Size and Forecast, End-Use
    2. Hospitals
      1. Market Size and Forecast, By Region
    3. Clinics
      1. Market Size and Forecast, By Region
    4. Homecare Settings
      1. Market Size and Forecast, By Region
  12. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Product Type
          1. Autoinjectors
            1. Prefilled Syringes
              1. Nasal Devices
              2. Application
                1. Severe Hypoglycemia
                  1. Exercise-Induced Hypoglycemia
                  2. End-Use
                    1. Hospitals
                      1. Clinics
                        1. Homecare Settings
                      2. U.S.
                        1. Product Type
                          1. Autoinjectors
                            1. Prefilled Syringes
                              1. Nasal Devices
                              2. Application
                                1. Severe Hypoglycemia
                                  1. Exercise-Induced Hypoglycemia
                                  2. End-Use
                                    1. Hospitals
                                      1. Clinics
                                        1. Homecare Settings
                                      2. Canada
                                    2. Europe
                                      1. Market Size and Forecast
                                        1. Product Type
                                          1. Autoinjectors
                                            1. Prefilled Syringes
                                              1. Nasal Devices
                                              2. Application
                                                1. Severe Hypoglycemia
                                                  1. Exercise-Induced Hypoglycemia
                                                  2. End-Use
                                                    1. Hospitals
                                                      1. Clinics
                                                        1. Homecare Settings
                                                      2. U.K.
                                                        1. Product Type
                                                          1. Autoinjectors
                                                            1. Prefilled Syringes
                                                              1. Nasal Devices
                                                              2. Application
                                                                1. Severe Hypoglycemia
                                                                  1. Exercise-Induced Hypoglycemia
                                                                  2. End-Use
                                                                    1. Hospitals
                                                                      1. Clinics
                                                                        1. Homecare Settings
                                                                      2. Germany
                                                                      3. France
                                                                      4. Spain
                                                                      5. Italy
                                                                      6. Russia
                                                                      7. Nordic
                                                                      8. Benelux
                                                                      9. Rest of Europe
                                                                    2. APAC
                                                                      1. Market Size and Forecast
                                                                        1. Product Type
                                                                          1. Autoinjectors
                                                                            1. Prefilled Syringes
                                                                              1. Nasal Devices
                                                                              2. Application
                                                                                1. Severe Hypoglycemia
                                                                                  1. Exercise-Induced Hypoglycemia
                                                                                  2. End-Use
                                                                                    1. Hospitals
                                                                                      1. Clinics
                                                                                        1. Homecare Settings
                                                                                      2. China
                                                                                        1. Product Type
                                                                                          1. Autoinjectors
                                                                                            1. Prefilled Syringes
                                                                                              1. Nasal Devices
                                                                                              2. Application
                                                                                                1. Severe Hypoglycemia
                                                                                                  1. Exercise-Induced Hypoglycemia
                                                                                                  2. End-Use
                                                                                                    1. Hospitals
                                                                                                      1. Clinics
                                                                                                        1. Homecare Settings
                                                                                                      2. South Korea
                                                                                                      3. Japan
                                                                                                      4. India
                                                                                                      5. Australia
                                                                                                      6. Singapore
                                                                                                      7. Taiwan
                                                                                                      8. South East Asia
                                                                                                      9. Rest of Asia-Pacific
                                                                                                    2. Middle East and Africa
                                                                                                      1. Market Size and Forecast
                                                                                                        1. Product Type
                                                                                                          1. Autoinjectors
                                                                                                            1. Prefilled Syringes
                                                                                                              1. Nasal Devices
                                                                                                              2. Application
                                                                                                                1. Severe Hypoglycemia
                                                                                                                  1. Exercise-Induced Hypoglycemia
                                                                                                                  2. End-Use
                                                                                                                    1. Hospitals
                                                                                                                      1. Clinics
                                                                                                                        1. Homecare Settings
                                                                                                                      2. UAE
                                                                                                                        1. Product Type
                                                                                                                          1. Autoinjectors
                                                                                                                            1. Prefilled Syringes
                                                                                                                              1. Nasal Devices
                                                                                                                              2. Application
                                                                                                                                1. Severe Hypoglycemia
                                                                                                                                  1. Exercise-Induced Hypoglycemia
                                                                                                                                  2. End-Use
                                                                                                                                    1. Hospitals
                                                                                                                                      1. Clinics
                                                                                                                                        1. Homecare Settings
                                                                                                                                      2. Turky
                                                                                                                                      3. Saudi Arabia
                                                                                                                                      4. South Africa
                                                                                                                                      5. Egypt
                                                                                                                                      6. Nigeria
                                                                                                                                      7. Rest of MEA
                                                                                                                                    2. LATAM
                                                                                                                                      1. Market Size and Forecast
                                                                                                                                        1. Product Type
                                                                                                                                          1. Autoinjectors
                                                                                                                                            1. Prefilled Syringes
                                                                                                                                              1. Nasal Devices
                                                                                                                                              2. Application
                                                                                                                                                1. Severe Hypoglycemia
                                                                                                                                                  1. Exercise-Induced Hypoglycemia
                                                                                                                                                  2. End-Use
                                                                                                                                                    1. Hospitals
                                                                                                                                                      1. Clinics
                                                                                                                                                        1. Homecare Settings
                                                                                                                                                      2. Brazil
                                                                                                                                                        1. Product Type
                                                                                                                                                          1. Autoinjectors
                                                                                                                                                            1. Prefilled Syringes
                                                                                                                                                              1. Nasal Devices
                                                                                                                                                              2. Application
                                                                                                                                                                1. Severe Hypoglycemia
                                                                                                                                                                  1. Exercise-Induced Hypoglycemia
                                                                                                                                                                  2. End-Use
                                                                                                                                                                    1. Hospitals
                                                                                                                                                                      1. Clinics
                                                                                                                                                                        1. Homecare Settings
                                                                                                                                                                      2. Mexico
                                                                                                                                                                      3. Argentina
                                                                                                                                                                      4. Chile
                                                                                                                                                                      5. Colombia
                                                                                                                                                                      6. Rest of LATAM
                                                                                                                                                                  3. Competitive Landscape, 2025
                                                                                                                                                                    1. Introduction
                                                                                                                                                                    2. Glucagon Delivery Device Market Share Analysis, 2025 (%)
                                                                                                                                                                      1. Market Share Analysis, 2025
                                                                                                                                                                      2. Competition Ranking, 2025
                                                                                                                                                                      3. Key Developments & Growth Strategies
                                                                                                                                                                        1. Merger & Acquisition
                                                                                                                                                                        2. Product Launch
                                                                                                                                                                        3. Expansion
                                                                                                                                                                      4. Consolidated SWOT Analysis of Key Players
                                                                                                                                                                  4. Company Profile
                                                                                                                                                                    1. Eli Lilly and Company
                                                                                                                                                                      1. Business Overview
                                                                                                                                                                      2. Financial Data
                                                                                                                                                                      3. Key Product Categories
                                                                                                                                                                      4. Recent Developments
                                                                                                                                                                    2. Novo Nordisk A/S
                                                                                                                                                                    3. Xeris Pharmaceuticals, Inc.
                                                                                                                                                                    4. Zealand Pharma A/S
                                                                                                                                                                    5. Pfizer Inc.
                                                                                                                                                                    6. Sanofi S.A.
                                                                                                                                                                    7. Amgen Inc.
                                                                                                                                                                    8. AstraZeneca plc
                                                                                                                                                                    9. Becton, Dickinson and Company
                                                                                                                                                                    10. Teva Pharmaceutical Industries Ltd.